Opus Genetics, Inc. Disclosure

Opus Genetics, Inc. (NASDAQ: IRD) is a client of PCG Advisory, Inc. IRD has an agreement in place to pay PCG a cash fee of $10,000 per month, for 6 months, for PCG investor awareness and investor relations advisory services.

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. PCG investor awareness and advisory services include multimedia marketing and other awareness services.